> Australian-based Peptech has announced that it has acquired the antibody assets of UK-based Scancell through its newly established U.K. subsidiary, Peptech UK. Report
> Chutes & Ladders: Blue Heron Biotechnology has named John Fess CEO. Mr. Fess succeeds John Mulligan, Ph.D., Blue Heron's founder who will become the company's board chairman and Chief Scientific Officer. Release
> Isis has received a $1 million milestone payment from Merck for initiating clinical trials of a new compound. Report
> China Health Holdings said it will acquire 51 percent or more ownership of China-based Xi'an Chunhui Pharmaceuticals. Release
And Finally... An outbreak of E. coli in New Jersey has been linked to Taco Bell restaurants. Report